Development of an International Prostate Cancer Outcomes Registry

Susan Evans, N. Nag, D. Roder, A. Brooks, J. L Millar, K.L. Moretti, D. Pryor, M. Skala, J.J. McNeil

Research output: Contribution to journalArticleOtherpeer-review

23 Citations (Scopus)

Abstract

Objectives: To establish a Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ) for monitoring outcomes of prostate cancer treatment and care, in a cost-effective manner.

Materials and Methods: Stakeholders were recruited based on their interest,importance in achieving the monitoring and reporting of clinical practice and patient outcome s, and in amalgamation of existing registries. Each participating jurisdiction isresponsible for local governance, site recruitment, data collection, and data transfer into the PCOR-ANZ. To establish each local registry, hospitals and clinicians within a jurisdiction were approached to voluntarily contribute to the registry following relevant ethical approval. Patient contact occurs following notification of prostate cancer through hospital or pathology report, or from a cancer registry.Patient registration is based on an opt-out model. The PCOR-ANZ is a secure web-based registry adhering to ISO27001 standards. Based on a standardised minimum data set, information on demographics, diagnosis, treatment, outcomes,and patient reported quality of life, are collected.

Results: Eight of nine jurisdictions have agreed to contribute to the PCOR-ANZ. Each jurisdiction has commenced implementation of necessary infrastructure to support rapid rollout. PCOR-ANZ has defined a minimum data set for collection , to enable analysis of key quality indicators that willaid in assessing clinical practice and patient focused outcomes.

Conclusion: PCOR-ANZ will provide a useful resource of risk-adjusted evidence-based data to clinicians, hospitals, and decision makers on prostate cancer clinical practice.
Original languageEnglish
Pages (from-to)60-67
Number of pages8
JournalBJU International
Volume117
Issue numberSupplement 4
DOIs
Publication statusPublished - 2016

Cite this

Evans, Susan ; Nag, N. ; Roder, D. ; Brooks, A. ; L Millar, J. ; Moretti, K.L. ; Pryor, D. ; Skala, M. ; McNeil, J.J. / Development of an International Prostate Cancer Outcomes Registry. In: BJU International. 2016 ; Vol. 117, No. Supplement 4. pp. 60-67.
@article{5e77d79680404189a7aa5b77946352b9,
title = "Development of an International Prostate Cancer Outcomes Registry",
abstract = "Objectives: To establish a Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ) for monitoring outcomes of prostate cancer treatment and care, in a cost-effective manner.Materials and Methods: Stakeholders were recruited based on their interest,importance in achieving the monitoring and reporting of clinical practice and patient outcome s, and in amalgamation of existing registries. Each participating jurisdiction isresponsible for local governance, site recruitment, data collection, and data transfer into the PCOR-ANZ. To establish each local registry, hospitals and clinicians within a jurisdiction were approached to voluntarily contribute to the registry following relevant ethical approval. Patient contact occurs following notification of prostate cancer through hospital or pathology report, or from a cancer registry.Patient registration is based on an opt-out model. The PCOR-ANZ is a secure web-based registry adhering to ISO27001 standards. Based on a standardised minimum data set, information on demographics, diagnosis, treatment, outcomes,and patient reported quality of life, are collected.Results: Eight of nine jurisdictions have agreed to contribute to the PCOR-ANZ. Each jurisdiction has commenced implementation of necessary infrastructure to support rapid rollout. PCOR-ANZ has defined a minimum data set for collection , to enable analysis of key quality indicators that willaid in assessing clinical practice and patient focused outcomes.Conclusion: PCOR-ANZ will provide a useful resource of risk-adjusted evidence-based data to clinicians, hospitals, and decision makers on prostate cancer clinical practice.",
author = "Susan Evans and N. Nag and D. Roder and A. Brooks and {L Millar}, J. and K.L. Moretti and D. Pryor and M. Skala and J.J. McNeil",
note = "Cited By :1 Export Date: 2 October 2016",
year = "2016",
doi = "10.1111/bju.13258",
language = "English",
volume = "117",
pages = "60--67",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "Supplement 4",

}

Development of an International Prostate Cancer Outcomes Registry. / Evans, Susan; Nag, N.; Roder, D.; Brooks, A.; L Millar, J.; Moretti, K.L.; Pryor, D.; Skala, M.; McNeil, J.J.

In: BJU International, Vol. 117, No. Supplement 4, 2016, p. 60-67.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Development of an International Prostate Cancer Outcomes Registry

AU - Evans, Susan

AU - Nag, N.

AU - Roder, D.

AU - Brooks, A.

AU - L Millar, J.

AU - Moretti, K.L.

AU - Pryor, D.

AU - Skala, M.

AU - McNeil, J.J.

N1 - Cited By :1 Export Date: 2 October 2016

PY - 2016

Y1 - 2016

N2 - Objectives: To establish a Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ) for monitoring outcomes of prostate cancer treatment and care, in a cost-effective manner.Materials and Methods: Stakeholders were recruited based on their interest,importance in achieving the monitoring and reporting of clinical practice and patient outcome s, and in amalgamation of existing registries. Each participating jurisdiction isresponsible for local governance, site recruitment, data collection, and data transfer into the PCOR-ANZ. To establish each local registry, hospitals and clinicians within a jurisdiction were approached to voluntarily contribute to the registry following relevant ethical approval. Patient contact occurs following notification of prostate cancer through hospital or pathology report, or from a cancer registry.Patient registration is based on an opt-out model. The PCOR-ANZ is a secure web-based registry adhering to ISO27001 standards. Based on a standardised minimum data set, information on demographics, diagnosis, treatment, outcomes,and patient reported quality of life, are collected.Results: Eight of nine jurisdictions have agreed to contribute to the PCOR-ANZ. Each jurisdiction has commenced implementation of necessary infrastructure to support rapid rollout. PCOR-ANZ has defined a minimum data set for collection , to enable analysis of key quality indicators that willaid in assessing clinical practice and patient focused outcomes.Conclusion: PCOR-ANZ will provide a useful resource of risk-adjusted evidence-based data to clinicians, hospitals, and decision makers on prostate cancer clinical practice.

AB - Objectives: To establish a Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ) for monitoring outcomes of prostate cancer treatment and care, in a cost-effective manner.Materials and Methods: Stakeholders were recruited based on their interest,importance in achieving the monitoring and reporting of clinical practice and patient outcome s, and in amalgamation of existing registries. Each participating jurisdiction isresponsible for local governance, site recruitment, data collection, and data transfer into the PCOR-ANZ. To establish each local registry, hospitals and clinicians within a jurisdiction were approached to voluntarily contribute to the registry following relevant ethical approval. Patient contact occurs following notification of prostate cancer through hospital or pathology report, or from a cancer registry.Patient registration is based on an opt-out model. The PCOR-ANZ is a secure web-based registry adhering to ISO27001 standards. Based on a standardised minimum data set, information on demographics, diagnosis, treatment, outcomes,and patient reported quality of life, are collected.Results: Eight of nine jurisdictions have agreed to contribute to the PCOR-ANZ. Each jurisdiction has commenced implementation of necessary infrastructure to support rapid rollout. PCOR-ANZ has defined a minimum data set for collection , to enable analysis of key quality indicators that willaid in assessing clinical practice and patient focused outcomes.Conclusion: PCOR-ANZ will provide a useful resource of risk-adjusted evidence-based data to clinicians, hospitals, and decision makers on prostate cancer clinical practice.

U2 - 10.1111/bju.13258

DO - 10.1111/bju.13258

M3 - Article

VL - 117

SP - 60

EP - 67

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - Supplement 4

ER -